TGA issues warning over rare eye disorder linked to Ozempic-like drugs

Australia's Therapeutic Goods Administration is flagging a rare but serious risk of vision impairment tied to GLP-1 drugs—medications like Ozempic and Wegovy that have surged in popularity for weight loss and diabetes management. The agency's new warning alerts users and prescribers to watch for potential vision complications.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton